|Articles|March 11, 2022
Single-Use Products Offer Advantages in Upstream Biopharmaceutical Process
Author(s)ILC Dover
Advertisement
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Beyond Transactional: Collaborative Partnerships for Rapid, Flexible Biologics Development
2
How FDA’s Bayesian Guidance Could Accelerate Adaptive Trial Design in Biopharmaceuticals
3
Novartis Calls for Global Governments to Address Global Trade Policy
4
